Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Jeffrey T. Jensen, Johannes Bitzer, Rossella E. Nappi, Christiane Ahlers, Ralf Bannemerschult & Susanne Parke. (2020) Pooled analysis of bleeding profile, efficacy and safety of oral oestradiol valerate/dienogest in women aged 25 and under. The European Journal of Contraception & Reproductive Health Care 25:2, pages 98-105.
Read now
Read now
Franca Fruzzetti, Anna Maria Paoletti, Tiziana Fidecicchi, Giulia Posar, Riccardo Giannini & Marco Gambacciani. (2019) Contraception with estradiol valerate and dienogest: adherence to the method. Open Access Journal of Contraception 10, pages 1-6.
Read now
Read now
Qi Yu, Zirong Huang, Mulan Ren, Qing Chang, Zhongqi Zhang & Susanne Parke. (2018) Contraceptive efficacy and safety of estradiol valerate/dienogest in a healthy female population: a multicenter, open-label, uncontrolled Phase III study. International Journal of Women's Health 10, pages 257-266.
Read now
Read now
John Palacio-Cardona & Diana María Caicedo Borrero. (2017) Clinical behavior of a cohort of adult women with facial acne treated with combined oral contraceptive: ethinylestradiol 20 µg/dienogest 2 mg. International Journal of Women's Health 9, pages 835-842.
Read now
Read now
Paula Briggs, Marco Serrani, Kai Vogtländer & Susanne Parke. (2016) Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study. International Journal of Women's Health 8, pages 477-487.
Read now
Read now
Alessandra Graziottin. (2016) The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval. The European Journal of Contraception & Reproductive Health Care 21:2, pages 93-105.
Read now
Read now
Johannes Bitzer, Maria Jesusa Banal-Silao, Hans-Joachim Ahrendt, Jaime Restrepo, Marion Hardtke, Ulrike Wissinger-Graefenhahn & Dietmar Trummer. (2015) Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen). International Journal of Women's Health 7, pages 501-509.
Read now
Read now
Anita L Nelson. (2015) An update on new orally administered contraceptives for women. Expert Opinion on Pharmacotherapy 16:18, pages 2759-2772.
Read now
Read now
Robin Kroll, Larry Seidman, Nancy Ricciotti, Brandon Howard & Herman Weiss. (2015) A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation. The European Journal of Contraception & Reproductive Health Care 20:4, pages 249-258.
Read now
Read now
Rossella E Nappi, Marco Serrani & Jeffrey T Jensen. (2014) Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature. International Journal of Women's Health 6, pages 711-718.
Read now
Read now
Jeffrey T Jensen, Johannes Bitzer & Marco Serrani. (2013) Comparison of the pharmacologic and clinical profiles of new combined oral contraceptives containing estradiol. Open Access Journal of Contraception 4, pages 39-50.
Read now
Read now
Articles from other publishers (10)
Yakovleva M.A.Mayorova M.O., Kalinkina O.B., Tezikov Yu.V. & Lipatov I.S.. (2021) OPTITMIZATION OF MANAGEMENT TACTICS FOR PATIENTS WITH HEADACHE CAUSED BY ESTROGEN WITHDRAWAL. Natural resources of the Earth and environmental protection 2:2, pages 62-67.
Crossref
Crossref
Natalia V. Aganezova & Sergey S. Aganezov. (2021) Real clinical practice and contraception for young women with children. Gynecology 23:1, pages 25-32.
Crossref
Crossref
Galina B. Dikke. (2020) Needs, expectations and doubt users of hormonal contraceptives. Gynecology 22:1, pages 33-37.
Crossref
Crossref
V.N. Kasyan. (2020) Standard counseling for the choice of hormonal contraceptive for safe long-term use (literature review). Problemy reproduktsii 26:2, pages 87.
Crossref
Crossref
G. B. Dikke. (2019) Combined oral contraceptives with shortened hormone-free interval. Proven advantages of the therapy regime. Medical Council:13, pages 56-62.
Crossref
Crossref
Alessandra Graziottin & Audrey Serafini. (2016) Perimenstrual asthma: from pathophysiology to treatment strategies. Multidisciplinary Respiratory Medicine 11:1.
Crossref
Crossref
Nicolás Mendoza, Esperanza Soto & Rafael Sánchez-Borrego. (2016) Do women aged over 40 need different counseling on combined hormonal contraception?. Maturitas 87, pages 79-83.
Crossref
Crossref
Felice Petraglia, Susanne Parke, Marco Serrani, Uwe Mellinger & Thomas Römer. (2014) Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea. International Journal of Gynecology & Obstetrics 125:3, pages 270-274.
Crossref
Crossref
Nicolas Mendoza & Rafael Sanchez-Borrego. (2014) Classical and newly recognised non-contraceptive benefits of combined hormonal contraceptive use in women over 40. Maturitas 78:1, pages 45-50.
Crossref
Crossref
Marta Martín Millán & Santos Castañeda. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
615
634
.